دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Avoidable research waste in dermatology: what are the solutions?
H.C. Williams
doi : 10.1111/bjd.20755
Pregnancy in epidermolysis bullosa: long-awaited guidelines of care
A.W. Lucky, E. Pope
doi : 10.1111/bjd.20897
Another anti-interleukin (IL)-17 inhibitor: is there an advantage of blocking IL-17A and IL-17F?
Sascha Gerdes, Joerg Albrecht
doi : 10.1111/bjd.20959
Herpesvirus, serious and opportunistic infections associated with atopic dermatitis
Natalija Novak, Beatriz Cabanillas
doi : 10.1111/bjd.20982
Going global with assessing the acne burden: is the evidence worth the effort?
Luigi Naldi
doi : 10.1111/bjd.20983
Epidermal melanoma prognostic factors: a link to paracrine transforming growth factor-β signalling
Gyorgy Paragh
doi : 10.1111/bjd.20981
Targeting the itch–scratch vicious circle in atopic eczema
Sebastien Barbarot
doi : 10.1111/bjd.21027
The potential of gene therapy for recessive dystrophic epidermolysis bullosa*
K.S. Subramaniam, M.N. Antoniou, J.A. McGrath, S.M. Lwin
doi : 10.1111/bjd.20910
Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline*
D.T. Greenblatt, E. Pillay, K. Snelson, R. Saad, M. Torres Pradilla, S. Widhiati, A. Diem, C. Knight, K. Thompson, N. Azzopardi, M. Werkentoft, Z. Moore, D. Patton, K.M. Mayre-Chilton, D.F. Murrell, J.E. Mellerio
doi : 10.1111/bjd.20809
The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study*
Y. Zhao, L. Wu, Q. Lu, X. Gao, X. Zhu, X. Yao, L. Li, W. Li, Y. Ding, Z. Song, L. Liu, N. Dang, C. Zhang, X. Liu, J. Gu, J. Wang, S. Geng, Q. Liu, Y. Guo, L. Dong, H. Su, L. Bai, J.T. O’Malley, J. Luo, E. Laws, L. Mannent, M. Ruddy, N. Amin, A. Bansal, T. Ota, M. Wang, J. Zhang
doi : 10.1111/bjd.20690
Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate-to-severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long-term studies*
K. Kabashima, T. Matsumura, H. Komazaki, M. Kawashima, for the Nemolizumab JP01 andJP02 Study Group
doi : 10.1111/bjd.20873
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study*
R. Oliver, J.G. Krueger, S. Glatt, P. Vajjah, C. Mistry, M. Page, H. Edwards, S. Garcet, X. Li, B. Dizier, A. Maroof, M. Watling, A. el Baghdady, D. Baeten, L. Ionescu, S. Shaw
doi : 10.1111/bjd.20827
Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population-based cohort study*
J. Wan, D.B. Shin, M.N. Syed, K. Abuabara, A.R. Lemeshow, J.M. Gelfand
doi : 10.1111/bjd.20887
Magnitude and temporal trend of acne vulgaris burden in 204 countries and territories from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019*
H. Chen, T.C. Zhang, X.L. Yin, J.Y. Man, X.R. Yang, M. Lu
doi : 10.1111/bjd.20882
Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa*
K. Navrazhina, Y. Renert-Yuval, J.W. Frew, D. Grand, J. Gonzalez, S.C. Williams, S. Garcet, J.G. Krueger
doi : 10.1111/bjd.20642
Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration*
I. Cosgarea, A.T. McConnell, T. Ewen, D. Tang, D.S. Hill, M. Anagnostou, M. Elias, R.A. Ellis, A. Murray, L.C. Spender, P. Giglio, M. Gagliardi, A. Greenwood, M. Piacentini, G.J. Inman, G.M. Fimia, M. Corazzari, J.L. Armstrong, P.E. Lovat
doi : 10.1111/bjd.20889
Aetiology of tinea capitis in China: a multicentre prospective study*
X.-Q. Chen, D.-Y. Zheng, Y.-Y. Xiao, B.-L. Dong, C.-W. Cao, L. Ma, Z.-S. Tong, M. Zhu, Z.-H. Liu, L.-Y. Xi, M. Fu, Y. Jin, B. Yin, F.-Q. Li, X.-F. Li, P. Abliz, H.-F. Liu, Y. Zhang, N. Yu, W.-W. Wu, X.-C. Xiong, J.-S. Zeng, H.-Q. Huang, Y.-P. Jiang, G.-Z. Chen, W.-H. Pan, H. Sang, Y. Wang, Y. Guo, D.-M. Shi, J.-X. Yang, W. Chen, Z. Wan, R.-Y. Li, A.-P. Wang, Y.-P. Ran, J. Yu
doi : 10.1111/bjd.20875
Ultraviolet radiation exposure to the face in patients with xeroderma pigmentosum and healthy controls: applying a novel methodology to define photoprotection behaviour*
R.P.E. Sarkany, M. Canfield, M. Morgan, L. Foster, K. Johnstone, K. Sainsbury, V. Araujo-Soares, H.C. Wulf, J. Weinman, J. Walburn, S. Norton
doi : 10.1111/bjd.20899
Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid
H. Rashid, J.M. Meijer, M.C. Bolling, B. Horváth
doi : 10.1111/bjd.20881
Use of thermal imaging and a dedicated wound-imaging smartphone app as an adjunct to staging hidradenitis suppurativa
J.L. Ramirez-GarciaLuna, S.C. Wang, T. Yangzom, V. Piguet, J.S. Kirby, A. Alavi
doi : 10.1111/bjd.20884
Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real-world setting
K.A. Papp, M.J. Gooderham, L.E. Albrecht, M.-A. Raymond, C.W. Lynde
doi : 10.1111/bjd.20885
Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies
T. Gambichler, N. Hamdani, H. Budde, M. Sieme, M. Skrygan, L. Scholl, H. Dickel, B. Behle, N. Ganjuur, C. Scheel, N. Abu Rached, L. Ocker, R. Stranzenbach, M. Doerler, L. Pfeiffer, J.C. Becker
doi : 10.1111/bjd.20890
Telehealth for older adults with skin disease: a qualitative exploration of dermatologists’ experiences and recommendations for improving care
I. de Vere Hunt, S. van Egmond, V. Nava, R. Khodosh, J. Lester, A.S. Chiou, E. Linos
doi : 10.1111/bjd.20891
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practice
M.-E. Marniquet, J. Seneschal, A.-S. Darrigade, D. Staumont-Sallé, M. Jachiet, A. Nosbaum, M. Tauber, C. Abasq, M.-C. Ferrier Le Bouedec, C. Droitcourt, H. Aubert, C. Bernier, A. Soria, N. Raison-Peyron, F. Tétart, F. Aubin, M. Viguier, A. Valois, I. Kupfer-Bessaguet, T. Goronflot, S. Barbarot, for the Groupe de Recherche sur l’Eczéma Atopique (GREAT)
doi : 10.1111/bjd.20883
COVID-19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation
M. Kasperkiewicz, R. Strong, K. Mead, M. Yale, D. Zillikens, D.T. Woodley, A. Recke
doi : 10.1111/bjd.20906
The potential skin-lightening candidate, senolytic drug ABT263, for photoageing pigmentation
Ji Hee Park, Jeong Eun Yoon, Yul Hee Kim, Yeongeun Kim, Tae Jun Park, Hee Young Kang
doi : 10.1111/bjd.20893
Immunomodulatory and/or immunosuppressive drugs should not be stopped prior to skin tests for the assessment of drug allergy
F. Dezoteux, S. El Mesbahi, B. Tedbirt, J. Grosjean, S. Gautier, D. Lannoy, C. Nassar, F. Tétart, D. Staumont-Sallé
doi : 10.1111/bjd.20901
Accuracy of commercially available smartphone applications for the detection of melanoma
M.D. Sun, J. Kentley, P. Mehta, S. Dusza, A.C. Halpern, V. Rotemberg
doi : 10.1111/bjd.20903
No association between omalizumab use and risk of cancer: a nationwide registry-based cohort study
Zarqa Ali, Alexander Egeberg, Jacob P. Thyssen, Jennifer Astrup Sørensen, Christian Vestergaard, Simon Francis Thomsen
doi : 10.1111/bjd.20941
Surveying the attitudes of dermatologists regarding climate change
Karolina Mieczkowska, Thomas Stringer, John S. Barbieri, Mary Williams, Misha Rosenbach
doi : 10.1111/bjd.20900
The role of curettage as an intervention for basal cell carcinoma. Response to ‘Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments'
D. Mazzoni, J. Muir
doi : 10.1111/bjd.20878
Response to ‘The role of curettage as an intervention for basal cell carcinoma’. Re. ‘Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments’: reply from the authors
J. Thomson, S. Hogan, J. Leonardi-Bee, H.C. Williams, F.J. Bath-Hextall
doi : 10.1111/bjd.20950
Guidelines for managing pregnancy and childbirth in women with epidermolysis bullosa
doi : 10.1111/bjd.21068
Reducing the itchiness associated with atopic dermatitis: results from two long-term nemolizumab studies
doi : 10.1111/bjd.21071
Shared and differing inflammatory blood proteins in patients with hidradenitis suppurativa and psoriasis
doi : 10.1111/bjd.21072
The potential of gene therapy for recessive dystrophic epidermolysis bullosa
doi : 10.1111/bjd.21074
Measuring ultraviolet exposure to the face in patients with xeroderma pigmentosum
doi : 10.1111/bjd.21078
å‡�轻与特应性皮炎相关的瘙痒: 两项奈莫利ç� å�•æŠ—çš„é•¿æœŸç ”ç©¶ç»“æžœ
doi : 10.1111/bjd.21083
